Tempo Pharmaceuticals

Tempo Therapeutics is a regenerative medicine company developing a proprietary Microporous Annealed Particle (MAP) technology platform. The MAP technology utilizes micro-spherical hydrogel building blocks to create a porous, injectable scaffold that promotes rapid tissue integration and cellular infiltration without triggering a significant immune response. The company's lead programs focus on advanced wound care and surgical site reconstruction, aiming to improve outcomes in complex tissue repair scenarios. By modulating the mechanical and chemical properties of the MAP scaffolds, Tempo aims to provide off-the-shelf solutions for diverse regenerative needs, including chronic wounds and volumetric muscle loss.